Articles tagged with Gut Microbiota
Researchers found that gut microbiome analysis successfully distinguished healthy individuals from those with precancerous adenomatous polyps and invasive colorectal cancer. The composition of the gut microbiome was different for each group, leading to improved prediction of colorectal cancer presence.
Researchers found a strong connection between post-transplant gut microbiota diversity and outcomes, with patients having low diversity more likely to die from transplant-related causes. The study suggests that preserving gut microbiota diversity may improve stem cell transplant outcomes.
Researchers have discovered that populating GI tracts with Bacteroides species producing beta-lactamase enzyme protects good commensal bacteria from antibiotics. This finding suggests a potential new strategy for preserving the gut microbiome during antibiotic treatment.
A study of professional rugby players found that exercise increased the diversity of gut microbiota, which was positively correlated with a favourable metabolic profile and immune system response. Higher dietary protein intake also played a role in this association.
A recent study suggests that chronic disruption of circadian rhythms may contribute to inflammatory bowel disease and other harmful conditions. Consuming a high-fat, high-sugar diet can worsen the effects of circadian rhythm disruption on intestinal flora.
A new study found that breastfeeding promotes the development of beneficial bacteria in babies' guts, which may help prevent obesity, allergies, and other diseases later in life. The study, led by Professor Kim F. Michaelsen, examined gut microbiota in 330 Danish children over three years.
Researchers found that gut microbiota diversity and interaction networks vary significantly between children with and without autoantibodies, influencing the body's immune system. The study suggests that identifying parameters affecting negative microbiome characteristics can lead to new approaches in preventing autoimmune processes.
A study found that toxigenic C. difficile bacteria persistently colonize infants' guts for more than six months, posing a risk of spreading to vulnerable adults. The bacteria can cause severe disease in elderly individuals and those undergoing broad-spectrum antibiotics.
Researchers found that diet complexity affects gut bacteria composition, with complex diets promoting beneficial Lactobacillales and simple diets increasing harmful Proteobacteria. The study suggests steroid hormone nuclear receptors play a role in microbiota maintenance.
Low birth weight infants exhibit microbiome differentiation in their mouths, gut, and skin by day 15 after birth. The gut microbiome plays a significant role in this process, with changes driven by bacterial types associated with newborn infections and necrotizing enterocolitis.
A study published in Nature found that patients with type 2 diabetes have an altered gut microbiota, which can predict the risk of developing diabetes. The researchers developed a new model to analyze the metagenome and distinguish between patients with type 2 diabetes and healthy women.
A study published in PLOS Computational Biology found a link between the composition of an infant's gut microbiota and their growth rate. The researchers identified specific bacterial groups associated with expected or reduced growth rates, shedding light on the potential impact of early life gut microbiota on infant development.
Researchers are working to improve study design and sample collection to better understand the composition and effects of the gut microbiota. The American Gastroenterological Association hosted a World Summit on Gut Microbiota For Health, where experts discussed future research directions.
Functional bowel disorders affect 50% of patients consulting a gastroenterologist. Recent research suggests that gut microbiota plays a significant role in these conditions. The AGA reports on the latest findings and potential therapeutic avenues.
Fecal microbiota transplantation has been shown to be highly effective in treating recurrent Clostridium difficile infections, with over 90% of patients being cured within a short period. The treatment offers a rapidly acting alternative to standard antibiotic treatments.
A new study found that infants born by cesarean delivery and those strictly formula-fed have different gut bacteria than those delivered vaginally and breastfed. The researchers suggest that these early-life influences may impact the development of conditions like asthma, obesity, and type 1 diabetes.
A study published in Applied and Environmental Microbiology found that changes in dietary cholesterol can alter the gut flora, leading to a shift in bacterial populations. The researchers discovered that this change triggered an increase in cholesterol excretion into the gut, which in turn affected the abundance of certain bacterial taxa.
Research suggests that pregnant women's gut microbes become less diverse and healthier bacteria decrease in abundance over time, promoting energy storage and supporting fetal growth. These changes can have negative consequences outside of pregnancy, leading to conditions like type 2 diabetes.
A study presented at the International Liver Congress 2012 suggests that gut microbiota transplantation can prevent the development of type 2 diabetes and non-alcoholic fatty liver disease. The study found that transplanting microbiota from healthy mice prevented insulin resistance and liver inflammation in germ-free mice.
The study reveals that gut microbiota modulates bile acid synthesis by altering the bile acid pool composition, reducing FXR inhibition in the small intestine.
A study by Caroline Karlsson found that rats fed a specific lactic acid bacteria HEAL19 had significantly less weight and inflammation compared to those without the bacteria. Additionally, babies born vaginally have lactobacilli in their gut flora as early as two days after birth.
Research reveals a strong association between nonalcoholic fatty liver disease (NAFLD) and both increased intestinal permeability and bacterial overgrowth in the small intestine. The study suggests that these factors contribute to the severity of steatosis, but not to more severe liver diseases like steatohepatitis or fibrosis.
A study found that treating cirrhotic patients with synbiotics or fermentable fiber can alter the gut flora, lowering ammonia levels and improving clinical signs of brain and liver dysfunction. The treatments were effective in reversing minimal hepatic encephalopathy in 50% of patients, compared to 13% in the placebo group.